Paolo Ghia
Università Vita-Salute San Raffaele
Professor of Medical Oncology
Italy
Paolo Ghia received his MD from the University of Torino, Italy, followed by a residency in Internal Medicine. He received his PhD working at the Basel Institute for Immunology, Basel, Switzerland. He moved to the Dana-Farber Cancer Institute, Harvard Medical School, Boston, where he studied the molecular mechanisms of the pathogenesis of follicular lymphoma.
He is now working in Milano, as Professor of Medical Oncology at the Università Vita-Salute San Raffaele; and Deputy Chairman of the Division of Experimental Oncology, at the Ospedale San Raffaele. He is Head of the Laboratory of B-Cell Neoplasia and Director of the Strategic Research Program on CLL, where he is National Coordinator or Principal Investigator in clinical trials in CLL, including phase 1 studies.
His research interest is the study of the molecular and cellular mechanisms acting in the natural history of Chronic Lymphocytic Leukemia (CLL), on which he has published over 260 manuscripts.
He is President of the European Research Initiative on CLL (ERIC), member of the International Workshop on CLL (iwCLL), of the WHO Clinical Advisory Committee for Lymphocytic and Histiocytic Malignancies for the topic Chronic Lymphocytic Leukemia, MBL, and PLL, of the steering board of the Working Party on Chronic lymphoproliferative disorders of the Italian Cooperative Group GIMEmA and Associate Editor for CLL at Hemasphere, the official Journal of the EHA. He coauthors the EHA-ESMO guidelines for CLL treatment. He is currently.